We are fortunate to advise world-class, industry-leading companies, helping them tackle novel, complex issues and push the boundaries of technological progress. Our ability and confidence to go to trial is our core strength; our deep bench of experienced trial lawyers represents companies in their most significant matters, helping them protect their intellectual property and launch products. Our lawyers pair extensive experience in the courtroom and the boardroom with a thorough understanding of science and technology.
Jennifer Gordon to Address Myriad and Mayo at PLI Seminar on Pharmaceutical and Biotech Patent Law
- Events
- September 27, 2016
Practices
Litigation counsel Jennifer Gordon will speak on a panel at the Practising Law Institute's "Developments in Pharmaceutical and Biotech Patent Law" seminar. Jennifer's panel, titled "Patentable Subject Matter in the Aftermath of Myriad and Mayo," will cover, among other topics, section 101 cases decided in the wake of Myriad and Mayo, an update on USPTO guidelines and strategies for the future. The event will take place on November 9 in New York City and December 9 in San Francisco.